DuPont de Nemours, Inc. Stock News

DuPont's diverse revenue streams and growing healthcare business make it a good long-term investment. Investors should wait for the stock to drop below $60 and yield 2.5% before buying. The company's

DuPont (DD) benefits from healthy demand in water and general industrial, growth though innovation and pricing actions amid weakness in consumer electronics and semiconductor markets.

The companies Chemours, DuPont and Corteva announced on Friday they have agreed to pay more than $1 billion to settle claims that "forever chemicals" contaminated public US water systems.

Markets rose after a strong jobs report and Senate passage of the debt ceiling bill, which will avoid a government default.

3M faces a bellwether trial over PFAS, set to begin Monday, that could set the tone for future lawsuits.

Dupont De Nemours Inc (NYSE:DD) stock is gapping higher today after news that the chemical name is joining Corteva (CTVA) and Chemours (CC) in setting up a $1.9 billion fund to settle multiple lawsui

Chemours Company, DuPont (NYSE:DD) de Nemours, Inc, and Corteva, Inc have jointly announced a settlement agreement in principle to comprehensively resolve all per and polyfluoroalkyl substances (PFAS)

The Chemours Co. CC, +2.34%, DuPont de Nemours Inc. DD, +0.37% and Corteva Inc. CTVA, +0.69% announced Friday an “agreement in principle” to settle all drinking water claims related to perfluoroal

Demand softness in certain markets, destocking and raw material cost inflation pose headwinds for the Zacks Chemicals Diversified industry. APD, DD, IOSP and KOP are poised to navigate the industry ch

The industrial drive by DuPont (DD) toward smaller, more powerful semiconductor chips is driving innovative advances in packaging applications such as 2.5D and 3D chip packages.

DuPont (DD) will additionally showcase battery pack thermal management solutions in energy storage applications during the exhibition.

DuPont (DD) gains on its focus on growth though innovation and pricing and productivity actions amid headwinds from sluggishness in some markets and input cost inflation.

Ari Wald, Oppenheimer managing director, joins ‘Power Lunch' to discuss three stocks: Alphabet, Dupont De Nemours and Charles Schwab.

Albemarle Corporation (NYSE:ALB) and DuPont de Nemours Inc (NYSE:DD) both sport healthy leads this morning, after analysts upgraded the two stocks.

Shares of DuPont de Nemours Inc. took a deep dive Tuesday, after the technology-based materials and plastics company lowered its full-year outlook, as weakness in the consumer electronics markets is s